VOTRIENT Reviews (PAZOPANIB HYDROCHLORIDE)

Average Rating: 5.0 (1 Ratings)

Filter Results

Compare VOTRIENT with similar:
 ANTINEOPLASTICS

 Type: Rx Drug

  

VOTRIENT  (PAZOPANIB HYDROCHLORIDE):  Pazopanib is used to treat kidney cancer. It may also be used to treat certain other types of cancer (soft tissue sarcoma). Pazopanib belongs to a class of drugs known as tyrosine kinase inhibitors. It works by decreasing the blood supply to the cancer tumor to slow tumor growth. This medication should not be used in children, especially younger than 2 years of age, because of the risk of serious side effects.   FDA Approval Date: 2009-10-19 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR VOTRIENTCOMMENTSSEXAGEDURATION/
DOSAGE		DATE ADDED
 
 5  Kidney cancer spread to lungs Initially, my feet were on fire for 1 1/2 weeks then went away. On going, I have frequent bouts with loose stools and an urgency to find a bath room/. Has been keeping my small tumors (>13 mm) stable or has shrunk them. Side effects minimal. I have never determined the actual cost of this drug - billed directly thru insurance. M 59 2.5 years
800 1X day		 5/5/2013
Email
  

VOTRIENT  (PAZOPANIB HYDROCHLORIDE):  Pazopanib is used to treat kidney cancer. It may also be used to treat certain other types of cancer (soft tissue sarcoma). Pazopanib belongs to a class of drugs known as tyrosine kinase inhibitors. It works by decreasing the blood supply to the cancer tumor to slow tumor growth. This medication should not be used in children, especially younger than 2 years of age, because of the risk of serious side effects.   FDA Approval Date: 2009-10-19 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP